Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 11;11(10):e41602.
doi: 10.2196/41602.

Community-Engaged Intervention Mapping for Cardiovascular Disease Prevention in Black and Latinx Sexual Minority Men With HIV in New York City: Protocol for a Web-Based Mixed Methods Study

Affiliations

Community-Engaged Intervention Mapping for Cardiovascular Disease Prevention in Black and Latinx Sexual Minority Men With HIV in New York City: Protocol for a Web-Based Mixed Methods Study

S Raquel Ramos et al. JMIR Res Protoc. .

Abstract

Background: Approximately every 37 seconds, someone in the United States dies of cardiovascular disease (CVD). It has emerged as an important contributor to morbidity among persons with HIV. Black and Latinx sexual minority men are at higher risk of both HIV and CVD when compared to heterosexual, nonethnic or minority men. Persons with HIV have a 1.5 to 2-times risk of having CVD than do HIV-negative persons. Data suggest that by the year 2030, an estimated 78% of persons with HIV will have CVD. The relationship between HIV and CVD in marginalized populations is not well understood because overall awareness of HIV and CVD as comorbid conditions is low, which further heightens risk. This has created a critically pressing issue affecting underrepresented ethnic and racial populations with HIV and requires immediate efforts to mitigate risk.

Objective: The purpose of this formative, mixed methods study is to use a community-engaged approach to map a behavioral intervention for CVD prevention in Black and Latinx sexual minority men with HIV in New York City.

Methods: Literature reviews focused on behavioral prevention studies using intervention mapping. In Aim 1, we will use qualitative interviews with HIV program managers and community members to understand facilitators and barriers to CVD prevention, chronic illnesses of concern, and early design elements needed for a web-based CVD prevention intervention. In Aim 2, we will conduct qualitative interviews and administer cross-sectional validated surveys with 30 Black and Latinx sexual minority men with HIV. We will assess illness perceptions of chronic conditions, such as HIV, hypertension, and diabetes. A total of 40 participants (program managers and community members) for Aims 1 and 2 will be enrolled to participate. To develop the protocol, we will follow steps 1 through 3 (needs assessment, change objectives, implementation strategy) of intervention mapping, using mixed methods.

Results: The study was approved by New York University Institutional Review Board in February 2021 (IRB-FY2021-4772) and also by the Yale University Institutional Review Board in June 2022 (#2000031577). We anticipate completing data collection on or before December 2022. Early analyses suggested concerns about illnesses outside of HIV and associated comorbid conditions, such as COVID-19 and monkeypox. Additionally, we noted a strong interest in using a web-based platform for CVD prevention education.

Conclusions: Web-based, behavioral, CVD prevention interventions may be promising modalities to closing the cardiovascular health disparities gap in Black and Latinx sexual minority men with HIV by extending the reach of prevention interventions using community-informed approaches and technological modalities that have been underused in this population.

International registered report identifier (irrid): RR1-10.2196/41602.

Keywords: Black men; CVD; HIV; Latinx; community based; community engagement; eHealth intervention; intervention mapping; men who have sex with men; qualitative; sexual minority men; survey.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Similar articles

Cited by

References

    1. American Heart Association As HIV patients live longer, heart disease might be their next challenge. https://www.heart.org/en/news/2019/06/03/as-hiv-patients-live-longer-hea.... 2019. [2022-05-10]. https://www.heart.org/en/news/2019/06/03/as-hiv-patients-live-longer-hea... .
    1. Tsao Connie W, Aday Aaron W, Almarzooq Zaid I, Alonso Alvaro, Beaton Andrea Z, Bittencourt Marcio S, Boehme Amelia K, Buxton Alfred E, Carson April P, Commodore-Mensah Yvonne, Elkind Mitchell S V, Evenson Kelly R, Eze-Nliam Chete, Ferguson Jane F, Generoso Giuliano, Ho Jennifer E, Kalani Rizwan, Khan Sadiya S, Kissela Brett M, Knutson Kristen L, Levine Deborah A, Lewis Tené T, Liu Junxiu, Loop Matthew Shane, Ma Jun, Mussolino Michael E, Navaneethan Sankar D, Perak Amanda Marma, Poudel Remy, Rezk-Hanna Mary, Roth Gregory A, Schroeder Emily B, Shah Svati H, Thacker Evan L, VanWagner Lisa B, Virani Salim S, Voecks Jenifer H, Wang Nae-Yuh, Yaffe Kristine, Martin Seth S. Heart disease and stroke statistics' 2022 update: a report from the American Heart Association. Circulation. 2022 Feb 22;145(8):e153–e639. doi: 10.1161/CIR.0000000000001052. https://www.ahajournals.org/doi/abs/10.1161/CIR.0000000000001052?url_ver... - DOI - DOI - PubMed
    1. Nordell Anna D, McKenna Matthew, Borges Álvaro H, Duprez Daniel, Neuhaus Jacqueline, Neaton James D, INSIGHT SMART‚ ESPRIT Study Groups. SILCAAT Scientific Committee Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. J Am Heart Assoc. 2014 May 28;3(3):e000844. doi: 10.1161/JAHA.114.000844. https://www.ahajournals.org/doi/abs/10.1161/JAHA.114.000844?url_ver=Z39.... jah3554 - DOI - DOI - PMC - PubMed
    1. Baker Jv, Sharma S, Achhra Ac, Bernardino Ji, Bogner Jr, Duprez D, Emery S, Gazzard B, Gordin J, Grandits G, Phillips An, Schwarze S, Soliman Ez, Spector Sa, Tambussi G, Lundgren J. Changes in cardiovascular disease risk factors with immediate versus deferred antiretroviral therapy initiation among HIV?positive participants in the START (Strategic Timing of Antiretroviral Treatment) Trial. JAHA. 2017 May 05;6(5):e004987. doi: 10.1161/jaha.116.004987. - DOI - PMC - PubMed
    1. Titanji B, Gavegnano C, Hsue P, Schinazi R, Marconi Vc. Targeting inflammation to reduce atherosclerotic cardiovascular risk in people with HIV infection. JAHA. 2020 Feb 04;9(3):e014873. doi: 10.1161/jaha.119.014873. - DOI - PMC - PubMed